Intellia Therapeutics NTLA Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Intellia Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellia Therapeutics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellia Therapeutics's total equity?
- Intellia Therapeutics (NTLA) reported total equity of $620.94M in Q1 2026.
- How has Intellia Therapeutics's total equity changed year-over-year?
- Intellia Therapeutics's total equity decreased by 20.4% year-over-year, from $779.92M to $620.94M.
- What is the long-term trend for Intellia Therapeutics's total equity?
- Over 5 years (2020 to 2025), Intellia Therapeutics's total equity has grown at a 5.0% compound annual growth rate (CAGR), from $527.07M to $671.39M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.